HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Robert A Hauser Selected Research

ropinirole (Requip)

5/2011Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's disease.
5/2010Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease.
5/2010Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
1/2010Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
12/2007Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
7/2004Ropinirole therapy for Parkinson's disease.
7/2003Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Robert A Hauser Research Topics

Disease

59Parkinson Disease (Parkinson's Disease)
11/2013 - 09/2002
26Dyskinesias (Dyskinesia)
11/2013 - 08/2003
9Essential Tremor (Essential Tremors)
07/2012 - 05/2005
8Nausea
04/2013 - 08/2003
8Tremor (Tremors)
11/2008 - 07/2002
7Chorea (Rheumatic Chorea)
03/2008 - 06/2005
5Parkinsonian Disorders (Parkinsonism)
11/2013 - 07/2005
4Huntington Disease (Huntington's Disease)
02/2013 - 06/2002
4Torticollis (Wryneck)
02/2013 - 09/2004
4Constipation
03/2011 - 01/2006
4Hallucinations (Hallucination)
01/2010 - 07/2004
3Dizziness (Lightheadedness)
07/2011 - 11/2008
3Dystonia (Limb Dystonia)
07/2007 - 12/2004
2Sleep Initiation and Maintenance Disorders (Insomnia)
04/2013 - 03/2011
2Deglutition Disorders (Dysphagia)
02/2013 - 09/2012
2Impulse Control Disorders (Kleptomania)
03/2010 - 01/2010
2Edema
01/2010 - 07/2004
2Disease Progression
01/2009 - 01/2005
2Pain (Aches)
03/2008 - 09/2004
2Myoclonus (Nocturnal Myoclonus)
07/2007 - 11/2002
1Movement Disorders (Movement Disorder)
03/2013
1Nervous System Diseases (Neurological Disorders)
02/2013
1Rhinitis
09/2012
1Craniocerebral Trauma (Head Injury)
01/2012
1Fatigue
11/2010
1Headache (Headaches)
04/2010
1Asthenia
04/2010
1Hypokinesia (Bradykinesia)
01/2009
1Spasm (Spasms)
09/2008
1Stiff-Person Syndrome (Stiff Man Syndrome)
09/2008
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2008
1Confusion (Bewilderment)
09/2006
1Paranoid Disorders (Paranoia)
05/2006
1Hyperhomocysteinemia
05/2006

Drug/Important Bio-Agent (IBA)

40Levodopa (L Dopa)FDA LinkGeneric
11/2013 - 09/2002
9etiracetam (levetiracetam)FDA LinkGeneric
09/2008 - 12/2004
8Dopamine Agonists (Dopamine Agonist)IBA
04/2010 - 01/2003
7Carbidopa (Lodosyn)FDA LinkGeneric
03/2013 - 09/2002
7ropinirole (Requip)FDA LinkGeneric
05/2011 - 07/2003
6pramipexol (pramipexole)FDA LinkGeneric
07/2012 - 12/2006
6Dopamine (Intropin)FDA LinkGeneric
11/2009 - 07/2003
5rasagiline (Azilect)FDA Link
06/2010 - 08/2004
5entacapone (Comtan)FDA Link
07/2009 - 01/2004
4StalevoIBA
07/2009 - 01/2004
3levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
04/2013 - 03/2009
3Botulinum Toxins (Botulinum Toxin)IBA
02/2013 - 07/2002
3istradefyllineIBA
11/2008 - 08/2003
2Amantadine (Aman)FDA LinkGeneric
11/2013 - 03/2013
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
11/2013 - 05/2008
2AdenosineFDA LinkGeneric
06/2013 - 01/2012
2preladenantIBA
06/2013 - 03/2011
2abobotulinumtoxinAFDA Link
02/2013 - 07/2005
2SLV-308IBA
07/2011 - 04/2010
2Selegiline (E250)FDA LinkGeneric
01/2010 - 04/2004
2Dopa DecarboxylaseIBA
07/2009 - 05/2007
2Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2008 - 08/2003
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
12/2007 - 05/2006
2pregabalin (Lyrica)FDA Link
08/2007 - 01/2007
2Prostaglandins B (PGB)IBA
08/2007 - 01/2007
2topiramate (Topamax)FDA LinkGeneric
05/2006 - 04/2006
1ioflupaneIBA
11/2013
1Neutralizing AntibodiesIBA
09/2012
1onabotulinumtoxinA (Botox)FDA Link
09/2012
1fipamezoleIBA
07/2012
12- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
07/2012
1SynucleinsIBA
01/2012
1Retinaldehyde (Retinal)IBA
06/2011
1salicylhydroxamic acid (SHAM)IBA
06/2011
1TEMPOIBA
06/2010
1amsonic acid (DAS)IBA
01/2010
1SolventsIBA
09/2009
12,4-Dichlorophenoxyacetic Acid (2,4 Dichlorophenoxyacetic Acid)IBA
09/2009
1BenserazideIBA
07/2009
1Dopamine Agents (Dopaminergic Agents)IBA
07/2009
1Dopamine Receptors (Dopamine Receptor)IBA
07/2009
1Glutathione (Reduced Glutathione)IBA
05/2009
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2009
1Caffeine (No Doz)FDA LinkGeneric
07/2008
1UbiquitinIBA
05/2008
1alpha-SynucleinIBA
05/2008
1gabapentin (Neurontin)FDA LinkGeneric
03/2008
1tiagabine (Gabitril)FDA Link
10/2007
1Monoamine Oxidase (MAO)IBA
05/2007
1TesofensineIBA
02/2007
1Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA
02/2007
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2007
1zonisamide (Zonegran)FDA LinkGeneric
01/2007
1HomocysteineIBA
05/2006
1VitaminsIBA
05/2006
1lamotrigine (Lamictal)FDA LinkGeneric
04/2006

Therapy/Procedure

8Activities of Daily Living (ADL)
03/2013 - 09/2002
4Transplantation (Transplant Recipients)
02/2013 - 06/2002
4Deep Brain Stimulation
01/2009 - 04/2006
3Injections
02/2013 - 07/2002
2Transplants (Transplant)
02/2013 - 05/2008
1Gastric Bypass (Roux-en-Y Gastric Bypass)
03/2013
1Homologous Transplantation (Allograft)
02/2013
1Drug Therapy (Chemotherapy)
06/2011
1Long-Term Care
09/2006
1Cell Transplantation
08/2006